Arca
Skip to content

RYR1: Ryanodine receptor 1

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Cytosolic calcium-activated calcium channel that mediates the release of Ca(2+) from the sarcoplasmic reticulum into the cytosol and thereby plays a key role in triggering muscle contraction following depolarization of T-tubules.

  • Drugs that act on it: 1
  • With a US drug page: 1
  • Type: Protein

Drugs That Act on It

Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page
DrugUS approvalMechanismActionWarnings
DantroleneApprovedRyanodine receptor 1 antagonistAntagonistBoxed warning

Diseases Most Associated With It

Open Targets association score, 0 to 1; all associations
Central core myopathy
0.85
Congenital multicore myopathy with external ophthalmoplegia
0.84
King-Denborough syndrome
0.80
Malignant hyperthermia of anesthesia
0.80
RYR1-related myopathy
0.70
Classic multiminicore myopathy
0.59
Ryr1-related disorders
0.58
Myopathy
0.57
Congenital fiber-type disproportion myopathy
0.57
Neuromuscular disease, congenital, with uniform type 1 fiber
0.57
Centronuclear myopathy
0.55
Hereditary disease
0.55

Drugs and mechanisms are from ChEMBL CHEMBL1846 (CC BY-SA 3.0). Gene name, function (UniProt P21817, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.